Approval · Notice of Compliance 18913 · 2017
EVRA: Notice of Compliance 18913
Issued January 27, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18913
- Date
- January 27, 2017
- Company
- Janssen Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change to the drug product specifications
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EVRA | Not yet assigned | — |
Medicinal ingredients
- ETHINYL ESTRADIOL 0.6 MG per UNIT
- NORELGESTROMIN 6 MG per UNIT